You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
20 February 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Friday that the US Food and Drug Administration (FDA) has accepted its New Drug Application for investigational oral giredestr...
20 February 2026 - Reacta Healthcare Ltd, a UK-based developer of food allergy diagnostic products, announced on Thursday the appointment of Richard Nagle as chair of its board of directors.Nagle has more than 30 years of experience in the pharmaceut...
20 February 2026 - Biopharmaceutical company Lario Therapeutics announced on Thursday that it has received a total of USD2.4m in grant funding from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Wellcome to support the continu...
19 February 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Thursday that the European Medicines Agency has validated a Type II variation application for Enhertu (trastuzumab deruxtecan) as monotherapy for adults with...
19 February 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Thursday reported positive second-season results from the Phase 3 SMART trial evaluating Enflonsia (clesrovimab) in infants and chi...
19 February 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) on Thursday announced a new agreement with Shreeji Imaging and Diagnostic Centre Pvt Ltd, an Indian manufacturer and distributor of f...
19 February 2026 - US-based AVEO Oncology, an LG Chem (KRX:051910) company, announced on Wednesday that the 20mg/kg dose of ficlatuzumab has been chosen for the combination arm of the Phase 3 registrational FIERCE-HN clinical trial following the plan...